Oncopeptides AB (ONCO) — Net Asset Quality Index
Oncopeptides AB (ONCO) has a Net Asset Quality Index of -43.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr134.84 Million minus total liabilities of Skr193.73 Million yields net assets of Skr-58.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Oncopeptides AB to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Oncopeptides AB Net Asset Quality Index Over Time (2014–2025)
This chart shows how Oncopeptides AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at -43.7%, representing net assets of Skr-58.89 Million against total assets of Skr134.84 Million SEK. See Oncopeptides AB current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Oncopeptides AB (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for Oncopeptides AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Oncopeptides AB (ONCO) market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -43.7% | Skr-58.89 Million | Skr134.84 Million | Skr193.73 Million | ▼ -65.9 pp |
| 2024 | 22.2% | Skr54.28 Million | Skr244.19 Million | Skr189.91 Million | ▼ -1.6 pp |
| 2023 | 23.8% | Skr56.78 Million | Skr238.38 Million | Skr181.60 Million | ▼ -52.6 pp |
| 2022 | 76.4% | Skr294.29 Million | Skr385.32 Million | Skr91.03 Million | ▲ +28.4 pp |
| 2021 | 48.0% | Skr210.87 Million | Skr439.38 Million | Skr228.51 Million | ▼ -12.9 pp |
| 2020 | 60.9% | Skr576.90 Million | Skr946.76 Million | Skr369.86 Million | ▼ -19.3 pp |
| 2019 | 80.2% | Skr797.01 Million | Skr993.49 Million | Skr196.47 Million | ▲ +9.2 pp |
| 2018 | 71.0% | Skr315.83 Million | Skr444.53 Million | Skr128.70 Million | ▼ -16.1 pp |
| 2017 | 87.1% | Skr418.00 Million | Skr479.82 Million | Skr61.82 Million | ▲ +39.8 pp |
| 2016 | 47.3% | Skr26.34 Million | Skr55.63 Million | Skr29.30 Million | ▲ +106.4 pp |
| 2015 | -59.1% | Skr-2.60 Million | Skr4.40 Million | Skr7.00 Million | ▼ -117.0 pp |
| 2014 | 58.0% | Skr7.61 Million | Skr13.12 Million | Skr5.52 Million | — |